Get notified about new articles
PRESS RELEASE: NuLiv Science Awarded Natural Product Number (NPN) from Health Canada to Expand Skin Health Ingredient, Astrion™, into Canadian Market
BREA, CA – Nuliv Science announced that its patented ingredient, Astrion™, has received a Natural Product Number (NPN) from Health Canada.
PRESS RELEASE: Zylaria™ Exhibits Strong Neuroprotective Activity by Improving GABA Release in New Study
Nuliv Science announced the findings of a new study on its mood and sleep ingredient, Zylaria™.
PRESS RELEASE: NuLiv Science Proudly Announces B-Corp Status
Company recognized for efforts in social and environmental performance, accountability, and transparency.
New human clinical study on InnoSlim® supports adiponectin and AMPK activation
NuLiv Science announced new research developments from a new human clinical study based on its IP ingredient, InnoSlim®.
NuLiv Science Receives Positive Clinical Study Results On Its 90-Day Toxicity Study For ASTRAGIN®
NuLiv Science received clinical study results for its 90-Day Toxicity Study on its flagship ingredient, AstraGin®
NuLiv Science Awarded Natural Product Number (NPN) From Health Canada To Expand Nutraceutical Ingredient, ASTRAGIN®, Into Canadian Market
AstraGin receives a NPN from Health Canada